Introduction
Social prescribing has been successfully rolled out across England since 2019, with millions of people referred to Link Workers and a growing evidence base to show the positive impact. As the NHS enters a new phase, it will be crucial to use data and evidence to develop and target social prescribing services further, evaluate the benefits and inform investment.
Our team at the Social Biobehavioural Research Group at UCL have formed a partnership with the National Academy for Social Prescribing (NASP) to develop a National Centre for Social Prescribing Data and Analysis. The partnership combines NASP’s reach into communities and expertise in policy development and advocacy with UCL’s world leading research and analysis capability.
About this event
Our first Centre webinar took place on Tuesday 21st October. The focus was reviewing major developments in social prescribing research from the past year. This included discussion of:
- How social prescribing relates to the NHS 10 year plan and in particular the implementation of Neighbourhood Health
- Growing awareness of social prescribing amongst the public
- The scale of social prescribing referrals and its ability to reach people from deprived areas
- Examples of large clinical trials currently underway across England and internationally
- New research to calculate the health economics of social prescribing
- Efforts to improve policy and practice, including through the Social Prescribing Youth Network
- Action needed to further enhance data quality and advance the evidence base
